Potential uses of omberacetam (Noopept©) in the early prevention and management of cognitive impairment

BACKGROUND. Cognitive impairment represents a growing global health challenge due to population aging and the increasing prevalence of chronic non-communicable diseases. Early stages of cognitive decline, including subjective cognitive decline and mild cognitive impairment, are considered the most p...

Descrizione completa

Dettagli Bibliografici

Autori principali:	O. N. Tkacheva, O. M. Drapkina, S. A. Berns, E. A. Mkhitaryan, M. A. Cherdak, N. N. Koberskaya, I. V. Kolykhalov, O. S. Zaitsev, S. N. Mosolov, S. V. Seredenin, Yu. V. Vakhitova, I. D. Strazhesko, M. V. Metlina
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	SSFIMT 2026-04-01
Serie:	Российский журнал гериатрической медицины
Soggetti:	cognitive impairment subjective cognitive decline mild cognitive impairment omberacetam noopept neuroprotection neuroplasticity cognitive health dementia prevention nootropics
Accesso online:	https://www.geriatr-news.com/jour/article/view/737
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!